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Objective To investigate the factors associated with maternal
death from direct pregnancy complications in the UK.
Design Unmatched case–control analysis.
Setting All hospitals caring for pregnant women in the UK.
Population A total of 135 women who died (cases) between
2009 and 2012 from eclampsia, pulmonary embolism, severe
sepsis, amniotic fluid embolism, and peripartum haemorrhage,
using data from the Confidential Enquiry into Maternal Death,
and another 1661 women who survived severe complications
(controls) caused by these conditions (2005–2013), using data
from the UK Obstetric Surveillance System.
Methods Multivariable regression analyses were undertaken to
identify the factors that were associated with maternal deaths and
to estimate the additive odds associated with the presence of one
or more of these factors.
Main outcome measures Odds ratios associated with maternal
death and population-attributable fractions, with 95% confidence
intervals. Incremental risk of death associated with the factors
using a ‘risk factors’ score.
Results Six factors were independently associated with maternal
death: inadequate use of antenatal care (adjusted odds ratio,
aOR 15.87, 95% CI 6.73–37.41); substance misuse (aOR 10.16, 95%
CI 1.81–57.04); medical comorbidities (aOR 4.82, 95% CI 3.14–
7.40); previous pregnancy problems (aOR 2.21, 95% CI 1.34–3.62);
hypertensive disorders of pregnancy (aOR 2.44, 95% CI 1.31–4.52);
and Indian ethnicity (aOR 2.70, 95% CI 1.14–6.43). Of the
increased risk associated with maternal death, 70% (95% CI 66–
73%) could be attributed to these factors. Odds associated with
maternal death increased by three and a half times per unit increase
in the ‘risk factor’ score (aOR 3.59, 95% CI 2.83–4.56).
Conclusions This study shows that medical comorbidities are
importantly associated with direct (obstetric) deaths. Further
studies are required to understand whether specific aspects of care
could be improved to reduce maternal deaths among women with
medical comorbidities in the UK.
Keywords Maternal mortality, risk factors, severe maternal
morbidity, UK.
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Introduction
Timely identification and appropriate management of fac-
tors that increase the risk of progression from severe
maternal morbidity to mortality have the potential to
improve pregnancy care and to prevent deaths. Several pre-
vious studies have identified a number of factors that are
thought to contribute to an increased risk of progression
from severe maternal morbidity to death, such as delay in
the identification of high-risk status and inappropriate
management and referral, inadequate antenatal care, and
suboptimal clinical care during delivery and postpartum.1–4
A previous study in the UK identified four characteristics
that were more frequent amongst women who died, com-
pared with women who had specific severe maternal mor-
bidities: older maternal age (>35 years); obesity; belonging
to unemployed or manual socio-economic groups; and
black Caribbean and African ethnic backgrounds.5 The data
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available for women who died limited the detailed investi-
gation of factors potentially underlying these associations,
however, in particular medical comorbidities, substance
misuse, inadequate antenatal care, and problems during the
current and previous pregnancies. The aim of the current
study was to further investigate the potential role of these
factors in the progression from severe morbidity to direct
maternal death among pregnant women in the UK, by
undertaking a case–control study to investigate their associ-
ation with maternal death using new and more detailed
data on maternal deaths.
Methods
We performed an unmatched case–control analysis using
data on maternal deaths from 2009–12 reported through
the Mothers and Babies: Reducing Risk through Audits and
Confidential Enquiries across the UK (MBRRACE-UK)
Confidential Enquiry into Maternal Deaths,6 and data on
women who survived severe life-threatening complications
during pregnancy and childbirth between 2005 and 2013
from the UK Obstetric Surveillance System (UKOSS).7 Five
major causes of direct maternal deaths in the UK for which
data were available from both databases were included in
this analysis: eclampsia, pulmonary embolism, severe sepsis,
amniotic fluid embolism (AFE), and peripartum haemor-
rhage.
Morbidity data for pulmonary embolism and eclampsia
were collected through UKOSS between 2007 and 2009,8,9
and data for severe sepsis were collected between 2012 and
2013.10 Data on survivors of peripartum haemorrhage
(defined as severe haemorrhage requiring surgical interven-
tions, including uterine compression sutures and hysterec-
tomy) were obtained from studies conducted between 2009
and 2013.11,12 Morbidity data for AFE was accrued between
2005 and 2013.13 We identified 135 women who died from
these causes and a control group of 1661 who survived.
Data on a subset of the women with three of these condi-
tions (eclampsia, pulmonary embolism, and AFE) were
included in a previous study by Kayem et al.5 Conditions
were defined using standard case definitions.11,14
Details of the UKOSS methodology are described else-
where.7,15 Briefly, UKOSS is a research platform enabling
the investigation of uncommon disorders of pregnancy.7
Case notification cards are sent to nominated reporting
doctors and midwives in all consultant-led obstetric units
in the UK every month, with a ‘nil-reporting’ approach.
Details are collected on a data-collection form for each case
reported by the clinician responsible for managing the case.
Rigorous follow-up of non-responders ensures the com-
pleteness of the data set.7
Surveillance of maternal deaths in the UK is undertaken
through the MBRRACE-UK collaboration.6 Deaths of
women during or after pregnancy are identified through a
variety of sources, the majority being notified to the MBR-
RACE-UK office directly from the unit in which the mater-
nal death occurred. Other sources include coroners/
procurators fiscal or pathologists, local supervising author-
ity midwifery officers, members of the public, and inquest
reports from the media. In addition, case ascertainment is
cross-checked with routine birth and death vital statistics
records from the Office for National Statistics and the
National Records of Scotland. For every death reported,
basic demographic and clinical details are collected.
Fourteen known risk factors for severe maternal morbid-
ity and mortality were included as independent variables:
gestational diabetes; hypertensive disorders of pregnancy
during the current pregnancy; anaemia; multiple preg-
nancy; inadequate use of antenatal care services; smoking;
substance misuse; previous pregnancy problems; pre-exist-
ing medical conditions; parity; body mass index (BMI);
employment status; maternal age; and ethnicity.13,14,16–18
Women were categorised as having gestational diabetes,
hypertensive disorders of pregnancy, and anaemia during
the current pregnancy, based on clinician-recorded condi-
tions in the medical records. The variable ‘ethnicity’ refers
to the racial origin of women and not their culture, and
was categorised according to the UK national census classi-
fication.19 Maternal age, BMI, and parity were each cate-
gorised into three groups.14,17,20,21 In order to compare the
findings with that of the previous UK study,5 we also cate-
gorised parity and BMI into binary variables and re-cate-
gorised age and tested these in a separate regression model.
Medical comorbidities were grouped initially as a single
variable, and subsequently into 18 categories (Box 1).
With 135 cases (deaths) and 1661 controls (survivors),
our analysis had a power of 80% to detect an odds ratio of
1.6 or greater associated with fatality at a significance level
of P < 0.05 (two-tailed) for the risk factor that had the
highest prevalence among the controls (42% for nullipari-
ty), and an odds ratio of 9.6 or greater for substance mis-
use (0.2%), which had the lowest prevalence.
Statistical analysis
We conducted an initial descriptive analysis of cases and
controls to identify potential associated factors. A core
logistic regression model (model 1) was then built includ-
ing all 14 variables that were identified from previous liter-
ature to be associated with maternal death. None of the
independent variables were found to be highly correlated
with one another. We tested for plausible interactions
(between substance misuse and employment status, smok-
ing and employment status, pre-existing mental health
problems and use of antenatal care, and substance misuse
and use of antenatal care) by adding interaction terms, one
at a time, and subsequent likelihood ratio testing (LR-test,
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P < 0.05). As no significant interactions were observed, we
did not fit the interaction terms in the final multivariable
model in order to improve parsimony.
We tested the continuous variables maternal age and
BMI for deviations from linearity by fitting functional
polynomials in the univariable logistic regression models
with multiple transformations of the continuous vari-
ables.22 This suggested presence of nonlinear associations of
the continuous variables with the outcome, thus the vari-
ables were included as categorical variables in the logistic
regression model. To compare the results with the previous
study we re-ran the logistic regression analysis incorporat-
ing the re-categorised variables for parity, maternal age,
and BMI.5 This did not substantively change the results. In
addition, we conducted separate sensitivity analyses includ-
ing only the three conditions included in the previous
paper (AFE, pulmonary embolism, and eclampsia) or the
two new conditions (severe sepsis and haemorrhage). We
also examined a restricted model that included only data
collected between 2009 and 2012.
The proportion of missing data for most variables was
<0.8%, except BMI (8.2%), smoking (2.4%), and employ-
ment status (16%). On the basis of previous studies, we
assumed that the data were not missing at random and
included a proxy variable for the missing group.14,23 In
addition, a series of sensitivity analyses were performed by
assuming extreme scenarios and accordingly redistributing
the missing observations into the extreme groups; this did
not materially alter the results.
We further investigated the role of medical comorbidities
by examining different subgroups of comorbidity. We con-
ducted univariable analyses to assess the association of the
18 specific pre-existing medical comorbidities with the out-
come. Thirteen variables found to be associated with the
outcome at P < 0.05 (two-tailed) and those identified as
important factors associated with maternal morbidity and
mortality in previous literature were included in a second
multivariable logistic regression model (model 2). This was
followed by an additional exploratory regression analysis to
examine the factors that were associated with medical
comorbidities in the study population.
A ‘risk factors’ score was generated to understand the
additive odds associated with the presence of one or more
factors that were found to be statistically significantly asso-
ciated with maternal death. Using the method employed by
Kayem et al.,5 we assigned a score of one to each factor.
We also calculated the population attributable fraction
(PAF) for the ‘risk factors’ score and the individual factors
using standard methods for calculating PAF in case–control
studies.24 All analyses were performed using STATA 13
(StataCorp, College Station, TX, USA).
Results
Six factors were independently associated with maternal death
after controlling for other independent variables (Table 1).
The odds ratio of inadequate use of antenatal care was 15
times higher among women who died compared with women
who survived (adjusted odds ratio, aOR 15.87; 95% confi-
dence interval, 95% CI 6.73–37.41), and the odds of substance
misuse was ten-fold higher among cases compared with con-
trols (aOR 10.16; 95%CI 1.81–57.04).Women who died were
also found to have a four-fold higher odds of having any med-
ical comorbidity, and had more than two-fold higher odds of
problems during previous pregnancies and hypertensive dis-
orders of pregnancy during the current pregnancy, compared
with the women who survived. Furthermore, the odds of
belonging to the Indian ethnic group was more than two and
a half times greater among cases compared with controls; this
was not observed for other ethnic minority groups. Model 1
explained 22% of the variance in the outcome.
The findings of the sensitivity analyses did not materially
differ from the results from model 1, with the exception of
ethnicity. The sensitivity analysis examining the disease
Box 1. Pre-existing medical conditions
Asthma Mental health problems
Autoimmune diseases (e.g. systemic lupus erythematosus) Haematological disorders (e.g. thalassemia, sickle-cell anaemia,
iron deficiency anaemia, and pro-coagulant states)
Known malignancies Epilepsy
Cardiac problems (congenital and acquired) Inflammatory disorders and allergic/atopic conditions (e.g. eczema
and ulcerative colitis)
Diabetes mellitus (types I or II) Essential hypertension
Diseases caused by blood-borne viruses (e.g. HIV, hepatitis B and C) Thrombotic events
Endocrine disorders, excluding diabetes mellitus (e.g. hypothyroidism
and hyperthyroidism)
Musculoskeletal disorders (e.g. osteoarthritis and hip replacement)
Renal problems (e.g. pyelonephritis, nephrectomy, and
recurrent urinary tract infection)
Other infections, excluding blood-borne viruses (e.g. sexually
transmitted infections, tuberculosis, and group–B Streptococcus infection)
Neurological disorders (e.g. migraine) Treated for infertility
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Table 1. Factors associated with maternal death from direct pregnancy complications (model 1)*
Risk factors Cases
no. (%) n = 135
Controls
no. (%) n = 1661
Unadjusted OR (95% CI) Adjusted OR* (95% CI)
Age (years)
<20 7 (5.2) 105 (6.3) 0.83 (0.37–1.84) 0.76 (0.29–2.03)
20–34 84 (62.2) 1044 (62.9) 1 1
≥35 44 (32.6) 512 (30.8) 1.06 (0.73–1.56) 0.94 (0.60–1.48)
Parity
Nulliparous 49 (36.3) 692 (41.7) 0.81 (0.55–1.19) 1.05 (0.62–1.78)
1–3 61 (45.2) 697 (41.9) 1 1
>3 23 (17.0) 269 (16.2) 0.98 (0.59–1.61) 0.79 (0.43–1.43)
Missing 2 (1.5) 3 (0.2) 7.62 (1.25–46.46) 1.22 (0.02–67.56)
Body mass index (kg/m2)
<18.5 6 (4.4) 45 (2.7) 1.83 (0.76–4.41) 1.56 (0.57–4.28)
18.5–30 84 (62.2) 1152 (69.4) 1 1
≥30 35 (25.9) 325 (19.6) 1.48 (0.98–2.23) 1.05 (0.66–1.70)
Missing 10 (7.4) 139 (8.3) 0.99 (0.50–1.95) 0.35 (0.13–0.94)
Multiple pregnancy
No 129 (95.5) 1588 (95.6) 1 1
Yes 4 (3.0) 73 (4.4) 0.67 (0.24–1.87) 0.67 (0.22–2.01)
Missing 2 (1.5) 0 (0.0) Omitted
Gestational diabetes
No 118 (87.4) 1605 (96.6) 1 1
Yes 8 (5.9) 50 (3.0) 2.18 (1.01–4.70) 1.43 (0.59–3.44)
Missing 9 (6.7) 6 (0.4) 20.40 (7.14–58.29)
Hypertensive disorders of pregnancy
No 106 (78.5) 1555 (93.6) 1 1
Yes 20 (14.8) 100 (6.0) 2.93 (1.75–4.93) 2.44 (1.31–4.52)
Missing 9 (6.7) 6 (0.4) 22.0 (7.69–62.98)
Anaemia
No 123 (91.1) 1632 (98.2) 1 1
Yes 3 (2.2) 23 (1.4) 1.73 (0.51–5.84) 2.39 (0.60–9.47)
Missing 9 (6.7) 6 (0.4) 19.90 (6.97–56.82)
Inadequate use of antenatal care**
No 106 (78.5) 1637 (98.6) 1 1
Yes 21 (15.6) 18 (1.1) 18.02 (9.32–34.84) 15.87 (6.73–37.41)
Missing 8 (5.9) 6 (0.3) 20.59 (7.02–61.43)
Smoking status
Non-smoker 95 (70.4) 1285 (77.4) 1 1
Smoker 27 (20.0) 346 (20.8) 1.05 (0.68–1.64) 0.79 (0.45–1.39)
Missing 13 (9.6) 30 (1.8) 5.86 (2.96–11.61) 2.92 (0.93–9.14)
Substance misuse
No 123 (91.1) 1651 (99.4) 1 1
Yes 6 (4.4) 4 (0.2) 20.13 (5.61–72.29) 10.16 (1.81–57.04)
Missing 6 (4.4) 6 (0.4) 13.42 (4.27–42.24) 2.94 (0.19–47.67)
Previous pregnancy problems***
No 76 (56.3) 1247 (75.1) 1 1
Yes 56 (41.5) 407 (24.5) 2.26 (1.57–3.25) 2.21 (1.34–3.62)
Missing 3 (2.2) 7 (0.4) 7.03 (1.78–27.73) 0.25 (0.01–5.32)
Pre-existing medical problems****
No 37 (27.4) 1175 (70.7) 1 1
Yes 93 (68.9) 481 (29.0) 6.14 (4.13–9.12) 4.82 (3.14–7.40)
Missing 5 (3.7) 5 (0.3) 31.76 (8.81–114.45) 18.93 (1.63–220.32)
Employment status
Employed 91 (67.4) 1211 (72.9) 1 1
Unemployed 17 (12.6) 188 (11.3) 1.20 (0.70–2.07) 1.27 (0.65–2.47)
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conditions separately (severe sepsis and haemorrhage in
one model and the other three conditions in another
model) showed that the odds ratio of belonging to the
Indian ethnic group was significantly higher among women
who died of severe sepsis and haemorrhage, compared with
women who survived these conditions (aOR 3.37, 95% CI
1.29–8.85), but that the same was not true for AFE, pulmo-
nary embolism, and eclampsia (aOR 0.98, 95% CI 0.09–
10.60). The odds ratios for the other ethnic minority
groups were not significantly different for cases and con-
trols.
The results of model 2 showed that eight of the 18 medi-
cal comorbidities were significantly associated with mater-
nal death (Table 2). The odds of pre-existing
musculoskeletal disorders was 12 times higher and the odds
of inflammatory/atopic disorders (excluding asthma) was
ten-fold higher among women who died compared with
women who survived. Women who died had five times
higher odds of suffering from autoimmune diseases and
infections, such as sexually transmitted infections, tubercu-
losis, and group–B Streptococcus infection, four-fold higher
odds of having a pre-existing haematological disorder, and
more than three times higher odds of essential hyperten-
sion, compared with the women who survived. The odds
of suffering from mental health problems and asthma were
more than two times higher among women who died,
compared with women who survived.
Analysis of the factors associated with medical comor-
bidities in the study population showed that women with
medical comorbidities had a significantly higher odds of
inadequate use of antenatal care, belonging to an older age
group (≥35 years), smoking, substance misuse, nulliparity,
obesity, gestational diabetes, hypertensive disorders of preg-
nancy, and problems during a previous pregnancy (Table
S1).
Analysis of the ‘risk factors’ score showed that half of
the women who survived did not have any of the six asso-
ciated factors, 38% had one, 12% had two, 1% had three,
and none had four or more. Among women who died,
19% did not have any of these associated factors, 27% had
one, 39% had two, 13% had three, and 1.5% (two women)
had four out of six associated factors. None of the women
had a score of more than four associated risk factors. The
odds associated with maternal death increased by more
than three and a half times per unit increase in the ‘risk
factor’ score (aOR 3.59; 95% CI 2.83–4.56; P < 0.001),
after controlling for other variables that are not included in
the score. On a population basis, 70% (95% CI 66–73%)
of the increased risk associated with maternal death could
be attributed to the six identified factors, the most impor-
tant being medical comorbidities followed by previous
pregnancy problems, hypertensive disorders of pregnancy,
inadequate use of antenatal care services, and Indian ethni-
city (Table 3).
Discussion
Main findings
We found six factors to be associated with maternal death
from direct pregnancy complications: inadequate use of
Table 1. (Continued)
Risk factors Cases
no. (%) n = 135
Controls
no. (%) n = 1661
Unadjusted OR (95% CI) Adjusted OR* (95% CI)
Missing 27 (20.0) 262 (15.8) 1.37 (0.87–2.15) 0.81 (0.44–1.51)
Ethnicity
White European 88 (65.2) 1226 (73.8) 1 1
Indian 8 (5.9) 47 (2.8) 2.37 (1.09–5.17) 2.70 (1.14–6.43)
Pakistani 7 (5.2) 73 (4.4) 1.34 (0.60–2.99) 2.10 (0.86–5.11)
Bangladeshi 2 (1.5) 39 (2.4) 0.71 (0.17–3.01) 1.21 (0.27–5.45)
Other Asian 4 (3.0) 66 (4.0) 0.84 (0.30–2.37) 1.08 (0.36–3.27)
Black Caribbean 3 (2.2) 40 (2.4) 1.04 (0.32–3.45) 0.93 (0.24–3.64)
Black African 13 (9.6) 105 (6.3) 1.72 (0.93–3.19) 1.09 (0.51–2.31)
Other/mixed 10 (7.4) 65 (3.9) 2.14 (1.06–4.32) 1.46 (0.59–3.61)
*Model 1 includes all 14 variables specified in the table.
**Inadequate use of antenatal care: women who concealed pregnancy, were late in booking an appointment, or who did not receive minimal
antenatal care.
***Previous pregnancy problems: women who were reported to have suffered from any pregnancy-related problem in a previous pregnancy, the
major categories of which included thrombotic events, placental problems, haemorrhage, pre-eclampsia, eclampsia, and puerperal psychosis.
****Pre-existing medical problems: women who were reported to have any medical comorbidity during the current pregnancy, including the 18
specific conditions described in Box 1. Women were categorised as having gestational diabetes, hypertensive disorders of pregnancy, or anaemia
based on clinician-recorded condition/s in the medical records.
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Table 2. Medical co-morbidities associated with maternal death from direct pregnancy complications (model 2)*
Risk factors Cases
no. (%) n = 135
Controls
no. (%) n = 1661
Unadjusted OR (95% CI) Adjusted OR* (95% CI)
Asthma
No 111 (82.2) 1562 (94.0) 1 1
Yes 19 (14.1) 94 (5.7) 2.84 (1.68–4.83) 2.36 (1.19–4.65)
Inflammatory disorders and allergic/atopic conditions (excluding asthma)
No 116 (85.9) 1645 (99.0) 1 1
Yes 14 (10.4) 11 (0.7) 18.05 (8.01–41.65) 9.79 (3.50–27.36)
Haematological disorders
No 117 (86.7) 1617 (97.4) 1 1
Yes 13 (9.6) 39 (2.3) 4.61 (2.39–8.87) 4.29 (1.88–9.76)
Infertility
No 122 (90.4) 1640 (98.7) 1 1
Yes 8 (5.9) 16 (1.0) 6.72 (2.82–16.02) 3.08 (0.87–10.84)
Neurological disorders
No 125 (92.6) 1650 (99.3) 1 1
Yes 5 (3.7) 6 (0.4) 11.00 (3.31–36.55) 3.83 (0.71–20.74)
Musculoskeletal disorders
No 120 (88.9) 1648 (99.2) 1 1
Yes 10 (7.4) 8 (0.5) 17.17 (6.65–44.30) 12.65 (3.56–44.98)
Mental health problems
No 110 (81.5) 1585 (95.4) 1 1
Yes 20 (14.8) 71 (4.3) 4.06 (2.38–6.91) 2.63 (1.28–5.44)
Infection (other than blood-borne
viruses)
No 122 (90.4) 1646 (99.1) 1 1
Yes 8 (5.9) 10 (0.6) 10.79 (4.18–27.84) 5.31 (1.63–17.23)
Essential hypertension
No 122 (90.4) 1626 (97.9) 1 1
Yes 8 (5.9) 30 (1.8) 3.55 (1.59–7.92) 3.35 (1.25–9.00)
Thrombotic event
No 125 (92.6) 1640 (98.7) 1 1
Yes 5 (3.7) 16 (1.0) 4.10 (1.48–11.38) 2.74 (0.68–11.08)
Autoimmune diseases
No 125 (92.6) 1637 (98.6) 1 1
Yes 5 (3.7) 19 (1.1) 3.45 (1.27–9.38) 5.16 (1.63–16.39)
Cardiac disease (congenital or acquired)
No 126 (93.3) 1632 (98.3) 1 1
Yes 4 (3.0) 24 (1.4) 2.16 (0.74–6.32) 1.32 (0.34–5.15)
Diabetes mellitus
No 127 (94.1) 1641 (98.8) 1 1
Yes 3 (2.2) 15 (0.9) 2.58 (0.74–9.04) 2.09 (0.50–8.79)
Blood-borne viruses
No 127 (94.1) 1644 (99.0) 1
Yes 3 (2.2) 12 (0.7) 3.24 (0.90–11.62) Excluded
Renal problems
No 126 (93.3) 1629 (98.1) 1
Yes 4 (3.0) 27 (1.6) 1.92 (0.66–5.56) Excluded
Endocrine disorders
No 127 (94.1) 1625 (97.8) 1
Yes 3 (2.2) 31 (1.9) 1.24 (0.37–4.11) Excluded
Known malignancies
No 129 (95.6) 1650 (99.3) 1
Yes 1 (0.7) 6 (0.4) 2.13 (0.25–17.84) Excluded
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antenatal care; substance misuse; medical comorbidities;
hypertensive disorders of pregnancy; previous pregnancy
problems; and Indian ethnicity. Together, these contributed
70% of the increased population risk. Belonging to other
ethnic minority backgrounds was also associated with
increased odds of death, but the odds ratios were not sta-
tistically significant, possibly because of a smaller number
of cases in each of these groups, resulting in low statistical
power. Specific medical comorbidities, including asthma,
autoimmune diseases, inflammatory/atopic disorders, men-
tal health problems, essential hypertension, haematological
disorders, musculoskeletal disorders, and infections, were
found to be associated with a higher risk of dying from the
conditions included in this study. Medical comorbidities
contributed 49% of the increased risk of fatality in the
study population.
Strengths and limitations
The low incidence of maternal mortality in the UK makes
studies on the risk of death among pregnant women who
develop severe morbidity difficult; however, we were able
to perform an unmatched case–control analysis using data
from two national databases to investigate the effects of
known factors associated with maternal mortality, and con-
ducted further analyses to investigate the association with
medical comorbidities. As the analysis was based on
national data, available from MBRRACE-UK and UKOSS,
the cases (maternal deaths) and controls (women who suf-
fered severe morbidity, but who survived) were from the
same source population, thereby making the comparison
valid.
Although the findings of the sensitivity analyses compar-
ing models for 2005–09 and 2009–13 did not differ from
the complete model, we cannot completely rule out any
bias arising from the differing time periods of data collec-
tion between UKOSS and MBRRACE-UK. We also cannot
rule out bias arising from the different data sources of cases
and controls. We specifically did not include cases of indi-
rect maternal death, as we wished to investigate the associa-
tion of medical comorbidities with direct maternal death;
this does mean that the findings cannot be generalised to
all maternal deaths, but are instead limited to the five con-
ditions causing the majority of direct maternal deaths in
the UK. We identified pre-existing medical conditions
based on clinician-reported general history. We do not
have information about the severity of these conditions
and modalities of treatment, which may have a differential
effect on the risk of progression to death. Thus, further
studies are required to examine these factors.
Interpretation (in light of other evidence)
The presence of medical comorbidities was significantly
more frequent among women who died compared with the
women who suffered severe morbidity but survived. Several
studies have demonstrated individual medical comorbidities
such as pre-existing asthma, hypertension, malignancy,
chronic ischaemic and congenital heart disease, chronic
renal disease, systemic lupus erythematosus, hypercoagula-
bility states, human immune deficiency virus, and diabetes
mellitus to be associated with both severe maternal mor-
bidity and mortality,18,25–31 but the extent of the popula-
tion risk attributable to medical comorbidities as a whole
Table 2. (Continued)
Risk factors Cases
no. (%) n = 135
Controls
no. (%) n = 1661
Unadjusted OR (95% CI) Adjusted OR* (95% CI)
Epilepsy
No 130 (96.3) 1642 (98.9) 1
Yes 0 (0.0) 14 (0.8) 1 (omitted) Excluded
Data were missing for five cases (3.7%) and for five controls (0.3%) with regards to all pre-existing medical conditions.
*Model 2 includes 13 of the 18 medical conditions listed in the table and all variables included in Table 1, except ‘pre-existing medical
conditions’. Five medical comorbidities were excluded from adjusted model 2 because they were not found to be significantly associated with the
outcome at P < 0.05 after univariable analysis: blood-borne viruses; renal problems; endocrine disorders; known malignancies; and epilepsy.
Diabetes mellitus and cardiac disease were retained in the model because these are known important risk factors for maternal morbidity and
mortality.
Table 3. Population-attributable fractions (PAFs) for specific
associated factors
Risk factors PAF (%) 95% CI
‘Risk factors’ score 69.8 66.1–73.0
Specific factors
Medical comorbidities 48.9 40.5–56.2
Previous pregnancy problems 21.1 11.7–29.5
Hypertensive disorders of pregnancy 12.0 7.7–16.1
Inadequate use of antenatal care 10.5 9.7–11.4
Indian ethnicity 2.9 0.3–5.5
Substance misuse 1 0.03–1.4
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Progression from severe maternal morbidity to death
in the UK has not previously been quantified. Uptake of
antenatal care was found to be poorer among women with
medical comorbidities in our study population, which
could increase the adverse effects associated with these con-
ditions. Our findings suggest that the association of older
maternal age and obesity with increased odds of dying
observed in a previous study,5 could be mediated through
medical comorbidities. Unlike other studies,18,25 we did not
find pre-existing diabetes mellitus and cardiac conditions
to be associated with maternal death. Whether this reflects
improved obstetric care of women with diabetes and car-
diac disease is unclear and requires further research.
Hypertension during pregnancy has been shown in other
analyses to be associated with an increased risk of intrace-
rebral haemorrhage, eclampsia, or end-organ dysfunction
culminating in death.3,32–34 Studies from different parts of
the world, including the UK, show a higher risk of mortal-
ity among women who do not receive adequate antenatal
care.3,14,33,35 Although there is a debate about the role of
antenatal care in preventing maternal deaths caused by
acute conditions that emerge close to the time of delivery,
its role in identifying pregnant women at high risk (such as
women with hypertensive disorders, medical comorbidities,
anaemia, and infections) and lowering their risk of mortal-
ity is widely accepted.36
Confidential enquiries into maternal deaths in the UK
have identified that a number of women who die during
or after pregnancy are substance misusers, although the
association with maternal death has not been formally
quantified before now.37,38 Studies have shown that women
who suffered problems during a previous pregnancy were
more likely to develop severe morbidity in subsequent
pregnancies.14,39,40 There is mixed evidence about ethnic
inequalities in maternal death. Whereas Kayem et al.5
found an association with black African and Caribbean
ethnicity in the UK, Geller et al.1 did not find any associa-
tion with minority ethnicity in the USA. Among the ethnic
minority groups examined in this study, the association
with maternal death was higher among the Indian group,
but only for sepsis and haemorrhage. This is likely to
explain the difference between our findings and the previ-
ous UK study, which did not include these conditions.5
Although factors such as pre-existing medical conditions,
previous pregnancy problems, and being of Indian origin
cannot be altered, their adverse consequences can be
potentially minimised through extra vigilance and proac-
tive management.
Conclusion
This national study has identified six risk factors associ-
ated with maternal death from direct pregnancy complica-
tions: inadequate use of antenatal care services; substance
misuse; medical comorbidities; hypertensive disorders of
pregnancy; previous pregnancy problems; and Indian eth-
nicity. Maternal deaths arising from indirect (medical)
causes now outnumber direct deaths arising from obstetric
causes in most high-resource countries, with mortality
rates either remaining static or increasing.38,41–44 This
study shows that medical comorbidities are also important
factors associated with deaths arising from obstetric causes
(direct deaths) in the UK: almost 50% of the population-
attributable risk is associated with the presence of medical
comorbidities. This highlights the importance of optimal
care for women with pre-existing medical problems in
pregnancy. Further studies are required to understand
whether specific aspects of care could be improved to
reduce maternal deaths among women with medical com-
orbidities.
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